SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041636
Filing Date
2021-08-05
Accepted
2021-08-05 16:31:48
Documents
46
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20210630.htm   iXBRL 10-Q 887997
2 EX-31.1 mack-ex311_7.htm EX-31.1 9569
3 EX-31.2 mack-ex312_9.htm EX-31.2 9570
4 EX-32.1 mack-ex321_6.htm EX-32.1 5719
5 EX-32.2 mack-ex322_8.htm EX-32.2 5719
  Complete submission text file 0001564590-21-041636.txt   2965170

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mack-20210630.xsd EX-101.SCH 27084
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20210630_cal.xml EX-101.CAL 20046
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20210630_def.xml EX-101.DEF 60919
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20210630_lab.xml EX-101.LAB 195202
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20210630_pre.xml EX-101.PRE 138571
11 EXTRACTED XBRL INSTANCE DOCUMENT mack-10q_20210630_htm.xml XML 386029
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 211148840
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences